Sphera Funds Management Ltd. Eli Lilly & CO Transaction History

Sphera Funds Management Ltd.

$380 Million
Q1 2025

A detailed history of Sphera Funds Management Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 11,690 shares of LLY stock, worth $8.89 Million. This represents 2.54% of its overall portfolio holdings.

Number of Shares

11,690

Previous 13,190 11.37%

Holding current value

$8.89 Million

Previous $10.2 Million 5.19%

% of portfolio

2.54%

Previous 2.1%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$725.72 - $929.72 $1.09 Million - $1.39 Million	-1,500 Reduced 11.37%	11,690 $9.65 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $724,870 - $909,040	-1,000 Reduced 7.05%	13,190 $11.9 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $652,050 - $898,949	-1,500 Reduced 9.56%	14,190 $7.62 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $5.61 Million - $7.5 Million	-16,000 Reduced 50.49%	15,690 $7.36 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $1.86 Million - $2.19 Million	6,000 Added 23.36%	31,690 $10.9 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $37.9 Million - $44.2 Million	-117,860 Reduced 82.1%	25,690 $9.4 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $3.35 Million - $3.82 Million	11,300 Added 8.54%	143,550 $46.4 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $17.3 Million - $20.3 Million	61,955 Added 88.14%	132,250 $42.9 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $21 Million - $26.1 Million	-89,400 Reduced 55.98%	70,295 $20.1 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $42.5 Million - $52.7 Million	-188,800 Reduced 54.18%	159,695 $44.1 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $36.9 Million - $45.4 Million	166,600 Added 91.59%	348,495 $80.5 Million
Q2 2021 Aug 17, 2021	SELL	$180.55 - $233.54 $44.7 Million - $57.8 Million	-247,305 Reduced 57.62%	181,895 $41.7 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $3.15 Million - $4.08 Million	19,200 Added 4.68%	429,200 $80.2 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $33.1 Million - $43.8 Million	254,000 Added 162.82%	410,000 $69.2 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $9.65 Million - $11.2 Million	66,000 Added 73.33%	156,000 $23.1 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $12.3 Million - $14.8 Million	90,000 New	90,000 $14.8 Million

Others Institutions Holding LLY

# of Institutions

4,401

Shares Held

807M

Call Options Held

9.92M

Put Options Held

10.9M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $722B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Account

Sphera Funds Management Ltd. Eli Lilly & CO Transaction History